Fenwick Represents Delfina Care in $17M Series A Funding

Fenwick represented Delfina Care, developer of a data-driven pregnancy care platform designed to offer a personalized prenatal care system, in its $17 million Series A funding. The round was led by US Venture Partners (USVP) with participation from new investors, including ARTIS Ventures, Mayo Clinic, Tokio Marine Future Fund, and existing investors.

Delfina will use the funds to expand growth and innovation, accelerate their ability to serve more patients nationwide, and enhance their industry-leading predictive technology and interventional support. More information can be obtained from the company announcement.

The Fenwick transaction team was led by corporate partners Dawn Belt and Taimur Case and included associates Alexej Ladonnikov and Blair Mills.